Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's adverse event reporting system.

Pera V, van Vaerenbergh F, Kors JA, et al. Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System. Pharmacoepidemiol Drug Saf. 2023;33(1):e5743. doi:10.1002/pds.5743.

Save
Print
February 21, 2024
Pera V, van Vaerenbergh F, Kors JA, et al. Pharmacoepidemiol Drug Saf. 2023;33(1):e5743.
View more articles from the same authors.

Medication errors and adverse drug events are an ongoing threat to patient safety. Using data from the Netherlands’ Food and Drug Administration’s Adverse Event Reporting System (FAERS) between 2004 and 2020, researchers found that 59% of reports were submitted by consumers and events most commonly involved chemotherapy and immunomodulating agents.

Save
Print
Cite
Citation

Pera V, van Vaerenbergh F, Kors JA, et al. Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System. Pharmacoepidemiol Drug Saf. 2023;33(1):e5743. doi:10.1002/pds.5743.

Related Resources From the Same Author(s)